Study of Biochemical and Hematological Markers in Patients Diagnosed with Basal Cell Carcinoma
Published Online: Aug 17, 2019
Page range: 26 - 30
DOI: https://doi.org/10.2478/arsm-2019-0006
Keywords
© 2019 Gurgas Leonard et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
In recent years, numerous scientific research papers have focused on the analysis of immunological, biochemical, ultrastructural, molecular and genetic factors that govern the clinical aspects of basal cell carcinomas. This retrospective study was carried out in the Clinical Department of Dermatovenerology at the County Emergency Clinical Hospital “Sf. Apostol Andrei”, Constanta. The research included a total of 140 patients treated in the clinic, with a diagnosis of basal cell epithelioma. We analyzed several biochemical and hematological markers including creatinine, male HDL cholesterol, female HDL cholesterol, LDL cholesterol, urea, serum glucose. More than half of patients with BCC present data of possible hepatic impairment and high atherogenic risk.